2.Differences of Energy Spectrum CT Findings between Small Cell Lung Cancer with Mediastinal Lymph Node Metastasis and Mediastinal Sarcoidosis.
Tuo MA ; Li Xiu CAO ; Hui Ju LI ; Hong Liang REN ; Da Peng CHEN ; Yuan GAO ; Zhi Dong LI ; Xin Bin ZHAO ; Si Qi DONG
Acta Academiae Medicinae Sinicae 2021;43(1):53-56
Objective To compare the differences of energy spectrum CT between small cell lung cancer(SCLC)with mediastinal lymph node metastasis and mediastinal sarcoidosis.Methods Twenty-five SCLC patients with mediastinal lymph node metastasis(SCLC group)and 26 patients with mediastinal sarcoidosis(sarcoidosis group)confirmed by bronchoscopy and biopsy in Tangshan People's Hospital from January 2018 to June 2019 were selected as the research objects.The CT value,iodine concentration,water concentration and energy spectrum curve slope under different single energy levels were compared between SCLC group and sarcoidosis group.Results The single-energy CT values of 40-80 keV segments in the arterial phase of the SCLC group were significantly higher than those in the sarcoidosis group(all P <0.05).The single-energy CT values of 90-140 keV segments were not significantly different from those in the sarcoidosis group(all P >0.05).The single-energy CT values of 40-90 keV segments in venous phase of the SCLC group were significantly higher than those of the sarcoidosis group(all P <0.05),and the single-energy CT values of 100-140 keV segments were not significantly different from those of the sarcoidosis group(all P >0.05).The concentrations of iodine in the arterial phase and venous phase of the SCLC group were(11.56±4.06)μg/cm
Humans
;
Lung Neoplasms/diagnostic imaging*
;
Lymph Nodes
;
Lymphatic Metastasis
;
Sarcoidosis/diagnostic imaging*
;
Small Cell Lung Carcinoma/diagnostic imaging*
;
Tomography, X-Ray Computed
3.Preoperative T stage of non-small cell lung cancer: comparison of the efficacy of 64-MDCT versus 3.0T MR imaging.
Wei TANG ; Ning WU ; Han OUYANG ; Yao HUANG ; Email: HUANGYAO93@163.COM. ; Li LIU ; Meng LI ; Lina ZHOU ; Xiaojuan XU
Chinese Journal of Oncology 2015;37(8):617-621
OBJECTIVETo compare the diagnostic efficacies of 64-MDCT and 3.0-T MRI in determining the T stage of non-small cell lung cancer (NSCLC).
METHODSApproval from the institutional ethics committee and informed consent from patients were obtained before the study started. 40 patients with NSCLC proved by pathology were enrolled in the study. All the 40 patients underwent non-enhanced MRI, enhanced MRI, and enhanced MDCT. Their T stages were preliminarily evaluated according to these imaging manifestations by 3 groups of experienced chest radiologists respectively, and correlated with that of postoperative pathology using the Kappa test. The diagnostic efficacies of these three imaging modalities for determining the T stage of NSCLC were compared using the McNemar test.
RESULTSThe preoperative diagnostic accuracy rate for the T stage of NSCLC was 85.0% (34 of 40) by non-enhanced MRI, 87.5% (35 of 40) by enhanced MRI, and 80.0% (32 of 40) by enhanced CT, showing no significant differences between the non-enhanced MRI and enhanced CT, enhanced MRI and enhanced CT, and non-enhanced MRI and enhanced MRI for determining the T stage of NSCLC (P>0.05).
CONCLUSIONSCompared with the enhanced MDCT, non-enhanced MRI and enhanced MRI provide slightly superior diagnostic efficacy for the preoperative T staging of NSCLC. For the patients with intolerance to contrast medium on MDCT scan, 3.0T MRI may be an alternative for determining the preoperative T stage of NSCLC.
Carcinoma, Non-Small-Cell Lung ; diagnostic imaging ; pathology ; Contrast Media ; Humans ; Lung Neoplasms ; diagnostic imaging ; pathology ; Magnetic Resonance Imaging ; Multidetector Computed Tomography ; Neoplasm Staging ; Preoperative Period
4.Postoperative Follow-up Should Not Be Neglected.
Chinese Journal of Lung Cancer 2018;21(3):205-205
5.Research Progress in Imaging-based Diagnosis of Benign and Malignant Enlarged Lymph Nodes in Non-small Cell Lung Cancer.
Chinese Journal of Lung Cancer 2023;26(1):31-37
Non-small cell lung cancer (NSCLC) can be detected with enlarged lymph nodes on imaging, but their benignity and malignancy are difficult to determine directly, making it difficult to stage the tumor and design radiotherapy target volumes. The clinical diagnosis of malignant lymph nodes is often based on the short diameter of lymph nodes ≥1 cm or the maximum standard uptake value ≥2.5, but the sensitivity and specificity of these criteria are too low to meet the clinical needs. In recent years, many advances have been made in diagnosing benign and malignant lymph nodes using other imaging parameters, and with the development of radiomics, deep learning and other technologies, models of mining the image information of enlarged lymph node regions further improve the diagnostic accuracy. The purpose of this paper is to review recent advances in imaging-based diagnosis of benign and malignant enlarged lymph nodes in NSCLC for more accurate and noninvasive assessment of lymph node status in clinical practice.
.
Humans
;
Carcinoma, Non-Small-Cell Lung/pathology*
;
Diagnostic Imaging
;
Lung Neoplasms/pathology*
;
Lymph Nodes/pathology*
;
Sensitivity and Specificity
6.Current status of 18F-FDG PET in predicting outcome of cancer therapy.
Chinese Journal of Oncology 2004;26(10):577-580
Breast Neoplasms
;
diagnostic imaging
;
Carcinoma, Non-Small-Cell Lung
;
diagnostic imaging
;
pathology
;
therapy
;
Fluorodeoxyglucose F18
;
Humans
;
Lung Neoplasms
;
diagnostic imaging
;
pathology
;
therapy
;
Lymphoma
;
diagnostic imaging
;
Neoplasm Recurrence, Local
;
diagnostic imaging
;
Neoplasm Staging
;
Neoplasm, Residual
;
Positron-Emission Tomography
;
Treatment Outcome
7.Advanced NSCLC first pass perfusion at 64-slice CT: reproducibility of volume-based quantitative measurement.
Fei SHAN ; Zhiyong ZHANG ; Mengsu ZENG ; Jie HU ; Chunxue BAI
Chinese Journal of Lung Cancer 2010;13(5):494-499
BACKGROUND AND OBJECTIVEThe aim of this study is to explore the reproducibility of volume-based quantitative measurement of non-small cell lung cancer (NSCLC) perfusion at 64-slice CT.
METHODSFourteen patients with proved advanced NSCLC were enrolled in this dynamic first pass volume-based CT perfusion (CTP) study (8x5 mm collimation), and they underwent the second scan within 24 h. According to the longest diameters, those patients were classified to <3 cm and >3 cm groups, and each group had 7 patients. Intradclass correlation coefficient (ICC) and Bland-Altman statistics were used to evaluate the reproducibility of CTP imaging.
RESULTSIn both groups of advanced NSCLC, the reproducibility with BF, BV, and PS values were good (ICC > 0.75 for all), but mean transit time (MTT) values. For advanced NSCLC (<3 cm), repeatability coefficient (RC) values with blood flow (BF), blood volume (BV), MT and permeability surface area product (PS) values were 56%, 45%, 114%, and 78%, respectively, and the 95% change intervals of RC were -39%-53%, -29%-62%, -83%-145%, and -57%-98%, respectively. For advanced NSCLC (>3 cm), those values were 46%, 30%, 59%, and 33%, respectively, and the 95% change intervals of RC were -48%-45%, -33%-26%, -54%-64%, and -18%-48%.
CONCLUSIONThere is greater reproducibility of tumor size >3 cm than that of < or =3 cm. BF and BV could be addressed for reliable clinical application in antiangiogenesis therapeutic monitoring with advanced NSCLC patients.
Adult ; Aged ; Carcinoma, Non-Small-Cell Lung ; diagnostic imaging ; Female ; Humans ; Lung Neoplasms ; diagnostic imaging ; Male ; Middle Aged ; Reproducibility of Results ; Tomography, X-Ray Computed ; methods
8.Mesh structure of two-dimensional tumor microvascular architecture phenotype heterogeneity in non-small cell lung cancer.
Zeng XIONG ; Hui ZHOU ; Jin-Kang LIU ; Cheng-Ping HU ; Mo-Ling ZHOU ; Yu XIA ; Jian-Hua ZHOU
Journal of Southern Medical University 2009;29(11):2215-2218
OBJECTIVETo investigate the structural characteristics and clinical significance of two-dimensional tumor microvascular architecture phenotype (2D-TMAP) in non-small cell lung cancer (NSCLC).
METHODSThirty surgical specimens of NSCLC were collected. The sections of the tumor tissues corresponding to the slice of CT perfusion imaging were selected to construct the 2D-TMAP expression. Spearman correlation analysis was used to examine the relation between the 2D-TMAP expression and the clinicopathological features of NSCLC.
RESULTSA heterogeneity was noted in the 2D-TMAP expression of NSCLC. The microvascular density (MVD) in the area surrounding the tumor was higher than that in the central area, but the difference was not statistically significant. The density of the microvessels without intact lumen was significantly greater in the surrounding area than in the central area (P=0.030). The total MVD was not correlated to tumor differentiation (r=0.042, P=0.831). The density of the microvessels without intact lumen in the surrounding area was positively correlated to degree of tumor differentiation and lymph node metastasis (r=0.528 and 0.533, P=0.041 and 0.028, respectively), and also to the expressions of vascular endothelial growth factor (VEGF), ephrinB2, EphB4, and proliferating cell nuclear antigen (PCNA) (r=0.504, 0.549, 0.549, and 0.370; P=0.005, 0.002, 0.002, and 0.048, respectively). The degree of tumor differentiation was positively correlated to PCNA and VEGF expression (r=0.604 and 0.370, P=0.001 and 0.048, respectively), but inversely to the integrity of microvascular basement membrane (r=-0.531, P=0.033).
CONCLUSIONThe 2D-TMAP suggests the overall state of the micro-environment for tumor growth. The 2D-TMAP of NSCLC regulates angiogenesis and tumor cell proliferation through a mesh-like structure, and better understanding of the characteristics and possible mechanism of 2D-TMAP expression can be of great clinical importance.
Adult ; Aged ; Capillaries ; ultrastructure ; Carcinoma, Non-Small-Cell Lung ; blood supply ; diagnostic imaging ; Female ; Humans ; Lung Neoplasms ; blood supply ; diagnostic imaging ; Male ; Middle Aged ; Tomography, Spiral Computed
9.A Case Report on Successful Third Challenge to the Pemetrexed-based Regimen for Advanced Non-small Cell Lung Cancer.
Linlin CHENG ; Emei GAO ; Fuxin ZHU ; Yuyan WANG ; Jia ZHONG ; Tongtong AN
Chinese Journal of Lung Cancer 2019;22(6):395-400
Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer, with a 5-year survival rate of less than 15%-19%, and more than 80% of the patients with lung cancer have progressed to advanced stage (Stage IIIb-IV) when they are clearly diagnosed. The comprehensive treatment mainly based on chemotherapy as the primary form is now considered as the major therapy method for advanced NSCLC without actionable driver gene mutations. Pemetrexed plus platinum doublet as well as single-agent pemetrexed are respectively the first-line major regimens recommended by guidelines and the second-line optional regimens. Yet the third-line treatment or beyond in advanced NSCLC is not evidence-based but conducted based on patients' previous medications, which is one of the most commonly used clinical methods. As pemetrexed is a multi-target chemotherapy drug with high efficiency but low toxicity, pemetrexed re-challenge strategy in advanced NSCLC is also a reasonable choice. We report one effective individual case that adopted pemetrexed re-challenge strategy in advanced NSCLC for three times, and at the same time conduct the relevant literature review.
Carcinoma, Non-Small-Cell Lung
;
diagnostic imaging
;
drug therapy
;
Female
;
Humans
;
Lung Neoplasms
;
diagnostic imaging
;
drug therapy
;
Middle Aged
;
Pemetrexed
;
administration & dosage
;
Positron Emission Tomography Computed Tomography
10.Application of Metabolic Parameters Measured by ¹⁸F-FDG PET/CT in the Evaluation of the Prognosis of Non-small Cell Lung Cancer.
Chinese Journal of Lung Cancer 2019;22(3):167-172
Tumor-node-metastasis (TNM) staging system is the most important basis for making therapeutic decisions and predicting prognosis of lung cancer patients. The metabolic parameters including standardized uptake value (SUV), metabolic tumor volume (MTV) and total lesion glycolysis (TLG) measured by ¹⁸F-fluorodeoxyglucose-positron emission tomography (¹⁸F-FDG PET/CT) associate with tumor aggressiveness and can provide additional prognostic information. A new staging methodology combines the conventional cTNM with the metabolic tumor burden quantified from the PET images is a better predictor of overall survival with superior stratifying power may help oncologists to make better treatment plans. ¹⁸F-FDG PET/CT image texture analysis, as an emerging research tool, is used to quantify the spatial heterogeneity of radioactive uptake in tumors, thereby to explore the biological characteristics of the tumor. This article reviews developments in evaluating the ¹⁸F-FDG PET/CT metabolic parameters and its role as a prognostic factor for non-small cell lung cancer.
.
Carcinoma, Non-Small-Cell Lung
;
diagnostic imaging
;
metabolism
;
Fluorodeoxyglucose F18
;
Humans
;
Image Processing, Computer-Assisted
;
Lung Neoplasms
;
diagnostic imaging
;
metabolism
;
Positron Emission Tomography Computed Tomography
;
methods
;
Prognosis